Cryptocurrency & Digital Assets

In a landmark decision, Jack Daniel's rare 14-year-old whiskey beat elite rivals in a blind tasting to claim the top honor from influential Bourbon Podcast.

Tired of ads and algorithms? Gistvox has launched an audio-only app with a radical idea: intentional listening. But can its unique business model survive?

Backed by top industry awards and advanced threat research, Acronis solidifies its MSP-first strategy with a unified platform built for the AI era.

Metallium's new Texas facility begins commissioning, using 'flash' tech to pull gold from e-waste, promising a greener, more secure US metal supply.

Capital Clean Energy Carriers Corp. orders three advanced LNG carriers, positioning itself to capitalize on a projected surge in global gas demand.

He helped land a Bible on the moon, but his final years were spent in state custody as his historic legacy became trapped in a bitter legal battle.

A new VR experience from Braindance uses a radical rendering method to make virtual worlds feel less like a game and more like a place you can truly occupy.

Rokid's new 'Style' line bets on affordability and design to bring AI wearables to the masses, building on proven tech and a rapidly growing open ecosystem.

Branded Legacy just wiped out $1M in legacy debt. The move is part of a radical overhaul by new management aimed at rebuilding investor confidence.

Eightco Holdings bets big on its own stock with a $125M buyback, banking on its Worldcoin treasury and a vision for AI-proof digital identity.

INOVIO's promising non-surgical treatment for a rare disease faces FDA scrutiny, casting doubt on its fast-track approval and impacting patient hopes.

With a new CEO and a booming market, mobile care provider instED is poised for major expansion. Here's what the move means for the future of healthcare.

Purina Foundation's 2025 grants extend beyond animal welfare, funding disaster relief, youth education, and veteran support in a strategic philanthropic push.

Syntiant unveils ultra-thin AI chips for hearables and smart remotes, aiming to dominate the booming market for miniaturized intelligent devices.

Verisk terminates its $2.35B AccuLynx acquisition after FTC delays, triggering a $1.5B debt redemption and a potential legal battle with the spurned firm.

A pivotal trial for an acute myeloid leukemia drug is delayed for a promising reason: patients are surviving longer than anticipated, fueling cautious optimism.

TRON founder Justin Sun injects $18M into Nasdaq-listed Tron Inc., bolstering its crypto treasury and cementing its unique dual business model.

Sofie Biosciences begins late-stage trials for a novel PET scan targeting aggressive gastrointestinal cancers, a breakthrough that could redefine detection.

After a turbulent year, the sleep apnea device maker aims to prove its rocky product launch is behind it and convince investors of a strong 2026.

Anfield Energy appoints financial expert Lubica Niemann as CFO, signaling a strategic move to manage NASDAQ compliance and its ambitious US uranium production goals.